In cellular and animal models of PD with mitochondrial defects, alterations in SIRT1 phosphorylation, decreased mitochondrial Sirtuin-3 (SIRT3) levels and reduced PGC-1α levels have been described. This evidence concerns the gene PPARGC1A and Parkinson disease.